Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seema A Bhat

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|November 16, 2019
Changing landscape of frontline therapy in chronic lymphocytic leukemiaSeema A Bhat, Jennifer A Woyach
The Oncologist|July 30, 2025
Considerations for the Practical Management of Cardiovascular Risk With Bruton's Tyrosine Kinase Inhibitors for Patients With CLLDaniel Lenihan, Michelle Bloom, Robert Copeland-Halperin, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 14, 2017
A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin LymphomaPallawi Torka, Priyank Patel, Wei Tan, et al.
Ejhaem|October 17, 2024
Incidence, description, and timing of serious and opportunistic infections in patients with hairy cell leukemiaNilesh Kapoor, Qiuhong Zhao, Andrew Stiff, et al.
American Journal of Hematology|February 15, 2024
Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysisAdam S Kittai, Ying Hang, Seema A Bhat, et al.
American Journal of Hematology|October 10, 2022
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinibAdam S Kittai, Ying Huang, Kyle A Beckwith, et al.
Hematological Oncology|April 3, 2023
Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization resultsMatthew R Avenarius, Ying Huang, Jonathan Hyak, et al.
JCI Insight|August 9, 2021
Optimizing extracellular vesicles' isolation from chronic lymphocytic leukemia patient plasma and cell line supernatantSara Elgamal, Emanuele Cocucci, Ellen J Sass, et al.
Leukemia|July 25, 2020
Second cancer incidence in CLL patients receiving BTK inhibitorsDavid A Bond, Ying Huang, James L Fisher, et al.
Blood|July 27, 2021
The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinibAdam S Kittai, Cecelia Miller, Daniel Goldstein, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|November 16, 2019
Changing landscape of frontline therapy in chronic lymphocytic leukemiaSeema A Bhat, Jennifer A Woyach
The Oncologist|July 30, 2025
Considerations for the Practical Management of Cardiovascular Risk With Bruton's Tyrosine Kinase Inhibitors for Patients With CLLDaniel Lenihan, Michelle Bloom, Robert Copeland-Halperin, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 14, 2017
A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin LymphomaPallawi Torka, Priyank Patel, Wei Tan, et al.
Ejhaem|October 17, 2024
Incidence, description, and timing of serious and opportunistic infections in patients with hairy cell leukemiaNilesh Kapoor, Qiuhong Zhao, Andrew Stiff, et al.
American Journal of Hematology|February 15, 2024
Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysisAdam S Kittai, Ying Hang, Seema A Bhat, et al.
American Journal of Hematology|October 10, 2022
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinibAdam S Kittai, Ying Huang, Kyle A Beckwith, et al.
Hematological Oncology|April 3, 2023
Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization resultsMatthew R Avenarius, Ying Huang, Jonathan Hyak, et al.
JCI Insight|August 9, 2021
Optimizing extracellular vesicles' isolation from chronic lymphocytic leukemia patient plasma and cell line supernatantSara Elgamal, Emanuele Cocucci, Ellen J Sass, et al.
Leukemia|July 25, 2020
Second cancer incidence in CLL patients receiving BTK inhibitorsDavid A Bond, Ying Huang, James L Fisher, et al.
Blood|July 27, 2021
The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinibAdam S Kittai, Cecelia Miller, Daniel Goldstein, et al.
Pageof 3